DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
CRASH-3 trial collaborators.
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
Lancet 2019;
394 (10210): 1713-1723
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.